Principle of Assay
17-Hydroxyprogesterone ELISA Kit (A3190) employs the competitive enzyme immunoassay technique for the quantitative measurement of 17-Hydroxyprogesterone in serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. The 96-well microtiter plate has been pre-coated with 17-Hydroxyprogesterone antigen. During the incubation, 17-Hydroxyprogesterone present in the samples or standards competes with the fixed amount of immobilized 17-Hydroxyprogesterone for binding sites on the Biotinylated Anti-17-Hydroxyprogesterone Antibody. The more 17-Hydroxyprogesterone present in a sample or standard, the less Biotinylated Anti-17-Hydroxyprogesterone Antibody that binds to the plate. Following incubation, unbound Biotinylated Anti-17-Hydroxyprogesterone Antibody is removed by washing, and an HRP-Avidin conjugate is added to the wells and the microtiter plate is incubated. Following incubation and washing, TMB substrate solution is then used to visualize the HRP enzymatic reaction by catalysis to produce a blue-coloured product that changes to yellow after addition of acidic stop solution. The density of yellow is inversely proportional to the amount of 17-Hydroxyprogesterone present in each sample or standard. The concentration of 17-Hydroxyprogesterone can then be calculated by reading the O.D. absorbance at 450nm in a microplate reader and referring to the standard curve.